LightDark Log in Sign up

‹ Back to screener

SYNGENE.NS Syngene International Ltd.

Healthcare

Price history

1M 6M 1Y 3Y Max
2025-08-21 ₹667.80
2026-08-21 ₹407.65
Change over window -38.96%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 57.8%
Trailing 20-day average 54.9%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 293096 169258 57.75%
2026-08-27 479502 252566 52.67%
2026-08-26 567950 242749 42.74%
2026-08-25 399141 208706 52.29%
2026-08-24 268563 144956 53.97%
2026-08-21 953583 475631 49.88%
2026-08-20 1883583 1173819 62.32%
2026-08-19 366481 167660 45.75%
2026-08-18 335081 203435 60.71%
2026-08-17 306199 200045 65.33%
2026-08-14 497308 295773 59.47%
2026-08-13 810276 448761 55.38%
2026-08-12 591399 378298 63.97%
2026-08-11 405459 218934 54.00%
2026-08-10 1885130 1227435 65.11%
2026-08-07 2260564 1438180 63.62%
2026-08-06 806023 352554 43.74%
2026-08-05 541762 276606 51.06%
2026-08-04 925377 442678 47.84%
2026-08-03 1674593 857211 51.19%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers SYNGENE.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
27 Dec 2024 ANJAN CHAKRABARTI Employees/Designated Employees Sell Market Sale 6190 5265152 0.01% XBRL
23 Dec 2024 ANJAN CHAKRABARTI Employees/Designated Employees Buy ESOP 58390 50199635 0.01% XBRL
23 Dec 2024 ANJAN CHAKRABARTI Employees/Designated Employees Sell Market Sale 27200 22944288 0.01% XBRL
11 Dec 2024 Biocon Limited Promoters Sell Market Sale 8000000 6861440000 52.46% XBRL
28 Nov 2024 DEEPAK VENKATRAMAN Employees/Designated Employees Sell Market Sale 600 533610 0.00% XBRL
28 Nov 2024 DEEPAK VENKATRAMAN Employees/Designated Employees Sell Market Sale 600 544290 0.00% XBRL
28 Nov 2024 Mayank Verma Employees/Designated Employees Sell Market Sale 1500 1369755 0.00% XBRL
18 Nov 2024 ALOK MEHROTRA Employees/Designated Employees Buy ESOP 20000 17520600 0.01% XBRL
18 Nov 2024 ALOK MEHROTRA Employees/Designated Employees Sell Market Sale 8200 7037404 0.01% XBRL
11 Nov 2024 SIBAJI BISWAS Key Managerial Personnel Buy ESOP 86431 76917540 0.04% XBRL
11 Nov 2024 SIBAJI BISWAS Key Managerial Personnel Sell Market Sale 35000 31977400 0.03% XBRL
05 Sep 2024 CHETAN PRAKASH TAMHANKA Employees/Designated Employees Sell Market Sale 2394 2091398 0.01% XBRL
04 Sep 2024 Ajit Manocha Employees/Designated Employees Sell Market Sale 2587 2276560 0.00% XBRL
03 Sep 2024 Ajit Manocha Employees/Designated Employees Sell Market Sale 2500 2180000 0.00% XBRL
29 Aug 2024 Ajit Manocha Employees/Designated Employees Sell Market Sale 5000 4225000 0.00% XBRL
28 Aug 2024 ALOK MEHROTRA Employees/Designated Employees Sell Market Sale 1000 853990 0.01% XBRL
28 Aug 2024 ALOK MEHROTRA Employees/Designated Employees Sell Market Sale 500 428540 0.01% XBRL
27 Aug 2024 G KRISHNAN Employees/Designated Employees Sell Market Sale 5000 4234400 0.00% XBRL
27 Aug 2024 Manoj Gupta Employees/Designated Employees Sell Market Sale 6400 5443200 0.00% XBRL
23 Aug 2024 CHETAN PRAKASH TAMHANKA Employees/Designated Employees Buy ESOP 17287 14386241 0.01% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers SYNGENE.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹407.25 INR (live) · fetched 2026-08-24 00:31 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score

Ratios

P/E
51.81
P/E = Price / EPS
Source trace
P/E = Price / (ProfitLossForPeriod / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹407.25 / (₹3,167,000,000 / 402,900,000 shares) = ₹407.25 / ₹7.86 EPS
FY2025-26 · Annual filing
ROE
6.54%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitLossForPeriod / EquityAttributableToOwnersOfParent → ₹3,167,000,000 / ₹48,391,000,000 = 6.54%
FY2025-26 · Annual filing
Debt/Equity
0.00
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹94,000,000 / ₹48,391,000,000 = 0.00
FY2025-26 · Annual filing
Current Ratio
1.38
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹21,428,000,000 / ₹15,523,000,000 = 1.38
FY2025-26 · Annual filing
ROCE
11.06%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹5,363,000,000 / (₹48,391,000,000 + ₹94,000,000) = 11.06%
FY2025-26 · Annual filing
Dividend Yield
0.31%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹504,000,000 / 402,900,000 shares) / ₹407.25 = ₹1.25 / ₹407.25
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 5.4%
Net Profit (3y) N/A
Revenue (5y, 3.0y actual) 5.4%
Net Profit (5y) N/A
Revenue (10y, 3.0y actual) 5.4%
Net Profit (10y) N/A

Operating Margin Trend

Eroding

FY2022-23 20.0%
FY2023-24 19.5%
FY2024-25 18.7%
FY2025-26 14.3%

ROCE Trajectory

FY2022-23 15.2%
FY2023-24 15.4%
FY2024-25 14.1%
FY2025-26 11.1%

Earnings Quality

Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.

Sector-Relative Percentile (Healthcare)

ROE 15th
ROCE 15th
Debt/Equity 76th
P/E 48th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹9.17 Bn ₹7.90 Bn ₹8.91 Bn ₹9.44 Bn ₹10.18 Bn ₹8.74 Bn ₹9.11 Bn ₹9.17 Bn ₹10.37 Bn ₹7.36 Bn RevenueFromOperations
Net Profit ₹1.89 Bn ₹0.76 Bn ₹1.06 Bn ₹1.31 Bn ₹1.83 Bn ₹0.87 Bn ₹0.67 Bn ₹0.15 Bn ₹1.48 Bn ₹-0.09 Bn ProfitLossForPeriod

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers SYNGENE.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitLossForPeriod3167000000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital402900000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets21428000000.0
CurrentLiabilities15523000000.0
EquityAttributableToOwnersOfParent48391000000.0
BorrowingsCurrent + BorrowingsNoncurrent94000000.0

My notes